These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15615640)

  • 1. Tau, tangles, and Alzheimer's disease.
    Binder LI; Guillozet-Bongaarts AL; Garcia-Sierra F; Berry RW
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):216-23. PubMed ID: 15615640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
    Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease.
    García-Sierra F; Ghoshal N; Quinn B; Berry RW; Binder LI
    J Alzheimers Dis; 2003 Apr; 5(2):65-77. PubMed ID: 12719624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsically disordered tau protein in Alzheimer's tangles: a coincidence or a rule?
    Skrabana R; Skrabanova M; Csokova N; Sevcik J; Novak M
    Bratisl Lek Listy; 2006; 107(9-10):354-8. PubMed ID: 17262987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
    Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
    Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.
    Kenessey A; Nacharaju P; Ko LW; Yen SH
    J Neurochem; 1997 Nov; 69(5):2026-38. PubMed ID: 9349548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
    Takeda M; Kudo T; Taniguchi N; Nishimura T
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurofibrillary degeneration and microtubule associated protein tau.
    Yen SH; Liu WK
    Chin J Physiol; 1992; 35(4):357-66. PubMed ID: 1308732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
    Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
    Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
    Götz J; Chen F; van Dorpe J; Nitsch RM
    Science; 2001 Aug; 293(5534):1491-5. PubMed ID: 11520988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tau.
    Xie C; Soeda Y; Shinzaki Y; In Y; Tomoo K; Ihara Y; Miyasaka T
    J Neurochem; 2015 Oct; 135(1):19-26. PubMed ID: 26134402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
    Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
    Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau oligomers and aggregation in Alzheimer's disease.
    Meraz-Ríos MA; Lira-De León KI; Campos-Peña V; De Anda-Hernández MA; Mena-López R
    J Neurochem; 2010 Mar; 112(6):1353-67. PubMed ID: 19943854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways of tau fibrillization.
    Kuret J; Chirita CN; Congdon EE; Kannanayakal T; Li G; Necula M; Yin H; Zhong Q
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):167-78. PubMed ID: 15615636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.